Study Evaluating the Antitumor Activity and Safety of Niraparib as Neoadjuvant Treatment in Participants With Breast Cancer
Clinical trial NCT03329937 · COMPLETED
Trial details
- NCT number
- NCT03329937
- Sponsor
- Tesaro, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-04-12
- Primary completion
- 2020-01-02
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.